Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial

被引:3
|
作者
Liu, Chun-I. [1 ]
Liu, Chih-Min [1 ,2 ]
Chiu, Huai-Hsuan [3 ]
Chuang, Chia-Chi [3 ]
Hwang, Tzung-Jeng [1 ,2 ]
Hsieh, Ming H. [1 ,2 ]
Chien, Yi-Ling [1 ,2 ]
Lin, Yi-Ting [1 ,2 ]
Yen, Ko [1 ]
Liu, Chen-Chung [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan
关键词
aripiprazole; concentration; dose tapering; minimum effective dose; schizophrenia; therapeutic drug monitoring; ACTIVE METABOLITE; SCHIZOPHRENIA; ARIPIPRAZOLE; DEHYDROARIPIPRAZOLE; DISCONTINUATION; RECOVERY;
D O I
10.1017/S0033291724002356
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Inconsistent results regarding the risk of relapse and better subjective outcomes of previous antipsychotic dose reduction trials in patients with remitted psychosis have not been verified using therapeutic drug monitoring (TDM). This study examined plasma drug concentrations of a dose-tapering trial which exhibited the potential of successful maintenance under lower antipsychotic dosages. Methods. A 2-year open-label randomized prospective trial recruited remitted patients to undergo guided antipsychotic tapering. Blood samples were collected at baseline, annually, and after each dose reduction. Plasma aripiprazole/dehydroaripiprazole concentrations were determined using LC-MS/MS. The relationship between the dose and serum drug levels was examined using Spearman's correlation. Divided at 120 ng/mL, relapse rate, global function, quality of life, and psychopathology were compared between high- and low- drug level groups. Results. A total of 126 blood samples were collected, after excluding13 samples due of non-adherence. The correlation coefficients between dosage and drug level were 0.853 (aripiprazole) and 0.864 (dehydroaripiprazole), and the dose and concentration plots were parallel along the tapering trajectories, except patients with non-adherence. The concentration-to-dose ratio of aripiprazole in this cohort, 17.79 +/- 7.23 ng/mL/mg, was higher than that in Caucasian populations. No significant differences were observed in the clinical outcomes between the high- and low-level groups. Remarkably, 12 of 15 patients maintained remission at plasma aripiprazole concentrations of <120 ng/mL. Conclusions. The lower-than-expected doses reached in our antipsychotic tapering trial were substantiated to provide adequate prophylactic effects by TDM results in a subset of patients treated with aripiprazole, even considering the differences in pharmacogenomics between ethnicities.
引用
收藏
页数:11
相关论文
共 5 条
  • [1] Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design
    Liu, Chen-Chung
    Hsieh, Ming H.
    Chien, Yi-Ling
    Liu, Chih-Min
    Lin, Yi-Ting
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    EARLY INTERVENTION IN PSYCHIATRY, 2022, 16 (02) : 178 - 185
  • [2] Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort
    Liu, Chen-Chung
    Hsieh, Ming H.
    Chien, Yi-Ling
    Liu, Chih-Min
    Lin, Yi-Ting
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    PSYCHOLOGICAL MEDICINE, 2023, 53 (15) : 7078 - 7086
  • [3] Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose
    Liu, Chen-Chung
    Hsieh, Ming H.
    Chien, Yi-Ling
    Liu, Chih-Min
    Lin, Yi-Ting
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    EUROPEAN PSYCHIATRY, 2023, 66 (01)
  • [4] MINIMUM EFFECTIVE DOSE OF ARIPIPRAZOLE DURING MAINTENANCE FOR PATIENTS IN REMITTED STATE OF PSYCHOSIS GUIDED BY AN EXPONENTIAL TAPERING METHOD: VERIFICATION BY PLASMA DRUG CONCENTRATION
    Liu, Chun-, I
    Yen, Ko
    Liu, Chen-Chung
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i87 - i88
  • [5] Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
    Liu, Chen-Chung
    Liu, Chih-Min
    Chien, Yi-Ling
    Lin, Yi-Ting
    Hsieh, Ming H.
    Hwang, Tzung-Jeng
    Hwu, Hai-Gwo
    FRONTIERS IN PSYCHIATRY, 2021, 12